Holders — by stockHoldings — by fund
Affinity Asset Advisors, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001773195
$2.21B
disclosed book value
110
positions
6%
largest position share
Positions, as of 2026-06-30
top 100 of 110 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD | 3.8M | $132.7M | 6% |
| 2 | APGEAPOGEE THERAPEUTICS INC | 987,000 | $131.0M | 5.9% |
| 3 | SYRESPYRE THERAPEUTICS INC | 1.3M | $113.6M | 5.1% |
| 4 | XENEXENON PHARMACEUTICALS INC | 1.6M | $96.3M | 4.4% |
| 5 | ERASERASCA INC | 5.3M | $96.2M | 4.3% |
| 6 | INSMINSMED INC | 650,000 | $69.3M | 3.1% |
| 7 | PRAXPRAXIS PRECISION MEDICINES I | 185,000 | $61.9M | 2.8% |
| 8 | ALKERMES PLC | 1.1M | $58.9M | 2.7% |
| 9 | ORKAORUKA THERAPEUTICS INC | 590,000 | $56.2M | 2.5% |
| 10 | ANABANAPTYSBIO INC | 826,109 | $55.8M | 2.5% |
| 11 | AVTXAVALO THERAPEUTICS INC | 2.9M | $53.6M | 2.4% |
| 12 | CYTKCYTOKINETICS INC | 550,000 | $46.9M | 2.1% |
| 13 | RVMDREVOLUTION MEDICINES INC | 250,000 | $46.8M | 2.1% |
| 14 | ABVXABIVAX SA | 330,000 | $44.0M | 2% |
| 15 | TRAXFIRST TRACKS BIOTHERAPEUTICS | 2.0M | $40.9M | 1.8% |
| 16 | DNTHDIANTHUS THERAPEUTICS INC | 400,000 | $39.0M | 1.8% |
| 17 | STROSUTRO BIOPHARMA INC | 1.2M | $38.9M | 1.8% |
| 18 | MRNAMODERNA INCPUT | 500,000 | $35.0M | 1.6% |
| 19 | NUVALENT INC | 275,000 | $34.0M | 1.5% |
| 20 | TRVITREVI THERAPEUTICS INC | 1.8M | $33.6M | 1.5% |
| 21 | MRNAMODERNA INCCALL | 475,000 | $33.3M | 1.5% |
| 22 | ARKGARK ETF TRCALL | 750,000 | $31.5M | 1.4% |
| 23 | OVIDOVID THERAPEUTICS INC | 10.1M | $27.3M | 1.2% |
| 24 | LXEOLEXEO THERAPEUTICS INC | 5.8M | $27.0M | 1.2% |
| 25 | CLDXCELLDEX THERAPEUTICS INC NEW | 700,000 | $26.0M | 1.2% |
| 26 | BLTEBELITE BIO INC | 165,000 | $25.4M | 1.1% |
| 27 | ELVNENLIVEN THERAPEUTICS INC | 500,000 | $25.4M | 1.1% |
| 28 | FBRXFORTE BIOSCIENCES INC | 1.1M | $24.3M | 1.1% |
| 29 | LLYELI LILLY & COCALL | 20,000 | $24.0M | 1.1% |
| 30 | NRIXNURIX THERAPEUTICS INC | 967,620 | $23.5M | 1.1% |
| 31 | ANROALTO NEUROSCIENCE INC | 850,000 | $22.4M | 1% |
| 32 | MDGLMADRIGAL PHARMACEUTICALS INC | 40,000 | $21.5M | 1% |
| 33 | PTGXPROTAGONIST THERAPEUTICS INC | 172,125 | $21.1M | 1% |
| 34 | MLYSMINERALYS THERAPEUTICS INC | 750,000 | $20.2M | 0.9% |
| 35 | RLAYRELAY THERAPEUTICS INC | 1.1M | $19.6M | 0.9% |
| 36 | SGMTSAGIMET BIOSCIENCES INC | 2.5M | $19.3M | 0.9% |
| 37 | JBIOJADE BIOSCIENCES INC | 840,350 | $18.7M | 0.8% |
| 38 | COGTCOGENT BIOSCIENCES INC | 450,000 | $17.4M | 0.8% |
| 39 | TVTXTRAVERE THERAPEUTICS INC | 300,000 | $17.0M | 0.8% |
| 40 | CGEMCULLINAN THERAPEUTICS INC | 875,760 | $15.9M | 0.7% |
| 41 | SVRASAVARA INC | 2.5M | $15.5M | 0.7% |
| 42 | IDYAIDEAYA BIOSCIENCES INC | 400,000 | $14.9M | 0.7% |
| 43 | CATXPERSPECTIVE THERAPEUTICS INC | 4.2M | $14.4M | 0.6% |
| 44 | ODTXODYSSEY THERAPEUTICS INC | 766,346 | $14.3M | 0.6% |
| 45 | COGT 1.625 11/15/31COGENT BIOSCIENCES INC | 11.0M | $13.7M | 0.6% |
| 46 | OMEROMEROS CORPPUT | 1.4M | $13.4M | 0.6% |
| 47 | HELIX ACQUISITION CORP III | 1.3M | $13.3M | 0.6% |
| 48 | EQEQUILLIUM INC | 4.1M | $13.1M | 0.6% |
| 49 | ALKERMES PLCCALL | 250,000 | $13.1M | 0.6% |
| 50 | ESTABLISHMENT LABS HLDGS INC | 148,013 | $12.7M | 0.6% |
| 51 | CLYMCLIMB BIO INC | 972,000 | $12.7M | 0.6% |
| 52 | TEVATEVA PHARMACEUTICAL INDS LTD | 374,000 | $12.7M | 0.6% |
| 53 | MANEVERADERMICS INC | 100,000 | $12.3M | 0.6% |
| 54 | ARWRARROWHEAD PHARMACEUTICALS IN | 150,000 | $12.2M | 0.6% |
| 55 | OMER 9.5 06/15/29OMEROS CORP | 6.5M | $12.2M | 0.6% |
| 56 | TSHATAYSHA GENE THERAPIES INC | 1.8M | $11.9M | 0.5% |
| 57 | DAMORA THERAPEUTICS INC | 425,000 | $11.1M | 0.5% |
| 58 | EPRXEUPRAXIA PHARMACEUTICALS INC | 1.6M | $10.9M | 0.5% |
| 59 | VERAVERA THERAPEUTICS INC | 250,000 | $10.7M | 0.5% |
| 60 | PROQR THRAPEUTICS N V | 5.5M | $10.3M | 0.5% |
| 61 | NEWAMSTERDAM PHARMA COMPANY | 275,000 | $9.3M | 0.4% |
| 62 | KRROKORRO BIO INC | 706,904 | $9.3M | 0.4% |
| 63 | UNIQURE NVCALL | 200,000 | $9.2M | 0.4% |
| 64 | AVRANTERIS TECHNOLOGIES GLOBAL | 912,397 | $9.0M | 0.4% |
| 65 | ZURA BIO LTD | 1.5M | $8.6M | 0.4% |
| 66 | UNIQURE NV | 175,000 | $8.1M | 0.4% |
| 67 | ASCENDIS PHARMA A/S | 30,000 | $8.0M | 0.4% |
| 68 | IBIOIBIO INC | 4.0M | $7.0M | 0.3% |
| 69 | GENBGENERATE BIOMEDICINES INC | 400,000 | $6.7M | 0.3% |
| 70 | EVMNEVOMMUNE INCPUT | 500,100 | $6.6M | 0.3% |
| 71 | TYRATYRA BIOSCIENCES INC | 200,012 | $6.4M | 0.3% |
| 72 | SOL-GEL TECHNOLOGIES LTD | 84,900 | $6.3M | 0.3% |
| 73 | SABSSAB BIOTHERAPEUTICS INC | 1.5M | $5.9M | 0.3% |
| 74 | MGNXMACROGENICS INC | 1.2M | $5.6M | 0.3% |
| 75 | CRISPR THERAPEUTICS AG | 100,000 | $5.5M | 0.2% |
| 76 | NEWAMSTERDAM PHARMA COMPANY | 245,000 | $5.3M | 0.2% |
| 77 | ASMBASSEMBLY BIOSCIENCES INC | 190,000 | $5.2M | 0.2% |
| 78 | RZLTREZOLUTE INC | 1.0M | $5.2M | 0.2% |
| 79 | DTILPRECISION BIOSCIENCES INC | 646,576 | $5.1M | 0.2% |
| 80 | COAGHEMAB THERAPEUTICS HLDGS INC | 138,030 | $5.1M | 0.2% |
| 81 | VRDNVIRIDIAN THERAPEUTICS INC | 250,000 | $4.6M | 0.2% |
| 82 | AVBPARRIVENT BIOPHARMA INC | 125,000 | $4.3M | 0.2% |
| 83 | VRCAVERRICA PHARMACEUTICALS INC | 707,338 | $4.3M | 0.2% |
| 84 | CMPSCOMPASS PATHWAYS PLC | 301,183 | $4.3M | 0.2% |
| 85 | MBXMBX BIOSCIENCES INC | 75,000 | $4.1M | 0.2% |
| 86 | RESEARCH ALLIANCE CORP III | 370,000 | $4.0M | 0.2% |
| 87 | IMVTIMMUNOVANT INC | 100,000 | $3.9M | 0.2% |
| 88 | AMANAT ACQUISITION CORP | 375,000 | $3.8M | 0.2% |
| 89 | BIOHAVEN LTD | 250,000 | $3.7M | 0.2% |
| 90 | FTHFAETH THERAPEUTICS INC | 144,404 | $3.6M | 0.2% |
| 91 | KPTIKARYOPHARM THERAPEUTICS INC | 312,500 | $3.1M | 0.1% |
| 92 | ALECALECTOR INC | 1.5M | $3.0M | 0.1% |
| 93 | SGPSPYGLASS PHARMA INC | 131,586 | $2.9M | 0.1% |
| 94 | CRNXCRINETICS PHARMACEUTICALS IN | 75,000 | $2.8M | 0.1% |
| 95 | OAKTREE ACQUISITION CORP III | 250,000 | $2.8M | 0.1% |
| 96 | CELC 0.25 08/01/32CELCUITY INC | 2.0M | $2.3M | 0.1% |
| 97 | JATT II ACQUISITION CORP | 200,000 | $2.3M | 0.1% |
| 98 | NMRANEUMORA THERAPEUTICS INC. | 1.1M | $1.8M | 0.1% |
| 99 | AMLXAMYLYX PHARMACEUTICALS INC | 98,999 | $1.8M | 0.1% |
| 100 | ANLADLAI NORTYE LTD | 153,847 | $1.8M | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.